Tranexamic acid and acute myocardial infarction

July 2005    Volume 12, Issue 4   Br J Cardiol 2005;12:306-7

Authors:
Amit KJ Mandal, Constatinos G Missouris

The plasminogen activator inhibitors have an important therapeutic role in controlling bleeding in patients with congenital and acquired coagulation disorders. They are being increasingly used in patients with blood loss and to prevent bleeding. However, these antifibrinolytic agents can also facilitate the development of thrombosis. We report a patient with severe gastrointestinal bleeding who developed acute myocardial infarction following the administration of the antifibrinolytic agent, tranexamic acid.

back to top

Comments

There are currently no comments for this article - leave a comment

You must be logged in to post a comment.
Not yet a member? Register now for free.

back to top